MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202647127465 A) filed by Isanaka, Ramakrishna Reddy on October 26, 2026, for Synthetic Peptide Is217 With Dual Antimicrobial And Immunomodulatory Activity For Treatment Of Sepsis.
Inventor includes Isanaka, Ramakrishna Reddy.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: The present invention relates to synthetic peptide IS217 or peptide variant thereof and formulations, combinations and/or compositions of said synthetic peptide IS217 or peptide variant thereof. The present invention provides antimicrobial, immunomodulatory and anti-inflammatory effects of the synthetic peptide IS217 or peptide v...